ONTX · Categories · Form 4

ONTX - SEC Form 4 insider transactions

Onconova Therapeutics Inc. (ONTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ONTX

• 791d
  Redfield Robert was granted 97,500 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 791d
  Pauza Charles David was granted 97,500 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 791d
  Cautreels Werner was granted 200,000 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 791d
  Savchuk Nikolay was granted 2,664,869 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 791d
  Dukes Iain D. was granted 1,779,337 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 810d
  Guerin Mark Patrick converted options into 8,666 shares and covered exercise/tax liability with 2,591 shares, increasing direct ownership by 20% to 35,976 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 810d
  Fruchtman Steven M converted options into 23,111 shares and covered exercise/tax liability with 8,727 shares, increasing direct ownership by 24% to 74,792 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 845d
  Guerin Mark Patrick converted options into 6,900 shares and covered exercise/tax liability with 2,443 shares, increasing direct ownership by 18% to 29,901 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 845d
  Fruchtman Steven M covered exercise/tax liability with 9,212 shares and converted options into 21,320 shares, increasing direct ownership by 25% to 60,408 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Shoemaker Mary Teresa

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Stover Jack E

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Atadja Peter

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Clarke Trafford

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Mehta Viren

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Groopman Jerome

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1024d
  SEC Form 4 filed by Marino James J

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1034d
  SEC Form 4: Guerin Mark Patrick covered exercise/tax liability with 1,422 shares and converted options into 4,750 shares, increasing direct ownership by 15% to 25,444 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1034d
  SEC Form 4: Fruchtman Steven M converted options into 12,567 shares and covered exercise/tax liability with 4,744 shares, increasing direct ownership by 19% to 48,300 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1086d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1177d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1177d
  SEC Form 4 filed by Fruchtman Steven M

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1177d
  SEC Form 4 filed by Gelder Mark S. Md

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1211d
  SEC Form 4: Fruchtman Steven M covered exercise/tax liability with 6,977 shares and converted options into 21,320 shares, increasing direct ownership by 55% to 40,477 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1211d
  SEC Form 4: Gelder Mark S. Md converted options into 5,833 shares and covered exercise/tax liability with 1,242 shares, increasing direct ownership by 78% to 10,487 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1211d
  SEC Form 4: Guerin Mark Patrick converted options into 6,900 shares and covered exercise/tax liability with 1,785 shares, increasing direct ownership by 39% to 18,191 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1262d
  SEC Form 4 filed by Clarke Trafford

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1262d
  SEC Form 4 filed by Atadja Peter

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1384d
  SEC Form 4 filed by Stover Jack E

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1384d
  SEC Form 4 filed by Marino James J

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1384d
  SEC Form 4 filed by Mehta Viren

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1384d
  SEC Form 4 filed by Shoemaker Mary Teresa

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1384d
  SEC Form 4 filed by Groopman Jerome

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1399d
  SEC Form 4: Guerin Mark Patrick converted options into 4,750 shares and covered exercise/tax liability with 1,355 shares, increasing direct ownership by 35% to 13,076 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1399d
  SEC Form 4: Gelder Mark S. Md converted options into 4,650 shares and covered exercise/tax liability with 1,135 shares, increasing direct ownership by 148% to 5,896 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1399d
  SEC Form 4: Fruchtman Steven M converted options into 12,566 shares and covered exercise/tax liability with 4,562 shares, increasing direct ownership by 44% to 26,134 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1451d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1575d
  SEC Form 4 filed by Gelder Mark S. Md

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1575d
  SEC Form 4 filed by Fruchtman Steven M

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1575d
  SEC Form 4 filed by Oler Abraham N.

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1575d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1584d
  SEC Form 4: Oler Abraham N. bought $2,505 worth of shares (1,500 units at $1.67), increasing direct ownership by 7% to 24,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1591d
  SEC Form 4: Oler Abraham N. bought $3,030 worth of shares (1,500 units at $2.02), increasing direct ownership by 7% to 23,014 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1597d
  SEC Form 4: Oler Abraham N. bought $3,300 worth of shares (1,500 units at $2.20), increasing direct ownership by 7% to 21,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1605d
  SEC Form 4: Oler Abraham N. bought $3,585 worth of shares (1,500 units at $2.39), increasing direct ownership by 8% to 20,014 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1653d
  SEC Form 4: Oler Abraham N. bought $3,160 worth of shares (1,000 units at $3.16), increasing direct ownership by 6% to 18,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1657d
  SEC Form 4: Oler Abraham N. exercised 5,000 in-the-money shares at a strike of $3.00, increasing direct ownership by 40% to 17,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1708d
  SEC Form 4: Oler Abraham N. bought $10,000 worth of shares (2,381 units at $4.20), increasing direct ownership by 23% to 12,515 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1708d
  SEC Form 4: Gelder Mark S. Md bought $10,000 worth of shares (2,381 units at $4.20)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1709d
  SEC Form 4: Fruchtman Steven M bought $10,000 worth of shares (2,381 units at $4.20), increasing direct ownership by 15% to 18,130 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1709d
  SEC Form 4: Marino James J bought $24,998 worth of shares (5,952 units at $4.20), increasing direct ownership by 39% to 21,334 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1764d
  SEC Form 4 filed by Fruchtman Steven M

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1764d
  SEC Form 4 filed by Gelder Mark S. MD

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1764d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1764d
  SEC Form 4 filed by OLER ABRAHAM N.

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1769d
  SEC Form 4 filed by STOVER JACK E

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1769d
  SEC Form 4 filed by Shoemaker Mary Teresa

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1769d
  SEC Form 4 filed by MEHTA VIREN

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1769d
  SEC Form 4 filed by MARINO JAMES J

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1769d
  SEC Form 4 filed by GROOPMAN JEROME

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1812d
  SEC Form 4 filed by Gelder Mark S. MD

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)

Other ONTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends